| Hans-Günter Meyer-Thompson | Hepatitiden
NIDA: Women who inject drugs may be at greater risk of HCV than men
There is a clear body of research assessing sex and gender differences in risk behaviors among people who inject drugs, however little or no research has investigated sex differences in hepatitis C (HCV) susceptibility. A newly published analysis examining data from more than 1800 people suggests that women who inject drugs have a 38% higher risk of contracting HCV than their male counterparts. Interestingly, while sharing of syringes and other injection equipment is a significant risk factor for HCV, differences in these behaviors did not account for the higher risk among women. The research was funded by the National Institute on Drug Abuse (NIDA), part of the National institutes of Health. (NIDA, USA, Spotlight on Research, 25.08.2017)